Contacts, documents and full notice history are available with a subscription.
Combined Synopsis/Solicitation NONE Expired 2 notices 4 documents

FY26 Pediatric FLU 75D30125R73357

Solicitation 75D30125R73357 Copied Notice ID e62f4dc5ffda4a6995908b7c831faa69 Copied HEALTH AND HUMAN SERVICES, DEPARTMENT OF — CDC OFFICE OF ACQUISITION SERVICES
SAM.gov
Posted
Aug 14, 2025
Deadline
Aug 28, 2025
Set-aside
NONE
NAICS
325412
PSC
6505

Summary

AI-generated · Aug 24, 2025

Contract opportunities exist for manufacturers of standard pediatric vaccines to supply vaccines under the Vaccine for Children (VFC) program. The VFC program provides federal funds to purchase vaccines for children 18 and younger who are Medicaid-eligible, uninsured, American Indian/Alaska Native, or insured children whose plan does not cover vaccines when immunizations are given at Federally-qualified health centers or rural health clinics. Awardees can supply vaccines to states at prices below the commercial market using VFC and Section 317 funds, and may offer additional quantities to immunize non-federally eligible children with state and local funds. Proposals must come from manufacturers of pediatric vaccines, defined as entities that manufacture, import, process, or distribute under their label any pediatric vaccine.

No substantive changes or new information differentiate these two notices; both describe the same requirement.

The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of pediatric vaccines for the purchase of standard commercial pediatric vaccines. Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children (VFC) program established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA 93), guarantees federal support for the purchase and supply of sufficient quantities of vaccine to the States to cover a defined group of children. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage. Children (18 years-of-age or younger) who qualify for immunization through the VFC purchase program include those who are (1) Medicaid-eligible, (2) without health insurance, (3) American Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA 93), or (4) children with health insurance, which does not cover the cost of vaccines, if they receive their immunizations at a Federally-qualified health center or rural health clinic (as defined by the Social Security Act). Health care providers who agree to certain requirements are eligible through the States to receive free vaccine through this VFC purchase program. The establishment of these contracts provides an opportunity to utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. In addition, awardees may opt to purchase additional quantities of vaccine under any resulting contract to provide immunizations for children who are not federally vaccine-eligible children using state and local funds. Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42 U.S.C. 1396s. The term "manufacturer" means any corporation, organization, or institution, whether public or private (including Federal, State, and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or distributes under its label any pediatric vaccine. The term "manufacture" means to manufacture, import, process, or distribute a vaccine

From Combined Synopsis/Solicitation posted on Aug 14, 2025

The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of pediatric vaccines for the purchase of standard commercial pediatric vaccines. Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children (VFC) program established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA 93), guarantees federal support for the purchase and supply of sufficient quantities of vaccine to the States to cover a defined group of children. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage. Children (18 years-of-age or younger) who qualify for immunization through the VFC purchase program include those who are (1) Medicaid-eligible, (2) without health insurance, (3) American Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA 93), or (4) children with health insurance, which does not cover the cost of vaccines, if they receive their immunizations at a Federally-qualified health center or rural health clinic (as defined by the Social Security Act). Health care providers who agree to certain requirements are eligible through the States to receive free vaccine through this VFC purchase program. The establishment of these contracts provides an opportunity to utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. In addition, awardees may opt to purchase additional quantities of vaccine under any resulting contract to provide immunizations for children who are not federally vaccine-eligible children using state and local funds. Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42 U.S.C. 1396s. The term "manufacturer" means any corporation, organization, or institution, whether public or private (including Federal, State, and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or distributes under its label any pediatric vaccine. The term "manufacture" means to manufacture, import, process, or distribute a vaccine

From Combined Synopsis/Solicitation posted on Aug 19, 2025

Notice history

2
  1. Combined Synopsis/Solicitation Posted Aug 14, 2025
  2. Combined Synopsis/Solicitation LATEST Posted Aug 19, 2025
    No changes from previous notice

Details

Solicitation number 75D30125R73357
Notice ID e62f4dc5ffda4a6995908b7c831faa69
Notice type Combined Synopsis/Solicitation
Product / Service (PSC) 6505
NAICS 325412
Set-aside No Set aside used
Place of performance Atlanta, Georgia
Archive date Sep 12, 2025

Award Information

Not yet awarded

Contacts

primary
James Sprigler

Email

secondary
Chad Turner

Email

Agency

HEALTH AND HUMAN SERVICES, DEPARTMENT OF
CENTERS FOR DISEASE CONTROL AND PREVENTION
CDC OFFICE OF ACQUISITION SERVICES

Place of Performance

Atlanta, Georgia
USA

Dates

Posted Aug 14, 2025 11 months ago
Last Updated Aug 06, 2026 2 days ago
Due Aug 28, 2025 11 months ago